
To validate each of the sinonasal outcome test (SNOT‐22) and the sinus and nasal quality of life (SN5) surveys for the adolescent population defined as 12 to 18 years old and to determine if they correlate regarding reports of sinonasal symptoms and quality of life. One hundred fifteen patients completed both surveys, 80 patients in the sinonasal cohort and 35 patients in the control cohort. Both surveys strongly predicted chronic sinonasal disorders with an odds ratio of 2.5 for SNOT‐22 and 2.2 for SN5. Therefore, both instruments can be used to study the outcome of treatment for sinonasal disorders in adolescent patients.
Like
Save
Share